137302-30-8

Basic information

• Product Name: 1,1-dimethylethyl <1-<<<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>amino>carbonyl>-3(S)-butenyl>carbamate
• Synonyms: 1,1-dimethylethyl <1-<<<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>amino>carbonyl>-3(S)-butenyl>carbamate
• CAS NO: 137302-30-8
• Molecular Weight: 560.682
• Mol File: 137302-30-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1,1-dimethylethyl <1-<<<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>amino>carbonyl>-3(S)-butenyl>carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: 1,1-dimethylethyl <1-<<<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>amino>carbonyl>-3(S)-butenyl>carbamate(137302-30-8)
• EPA Substance Registry System: 1,1-dimethylethyl <1-<<<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>amino>carbonyl>-3(S)-butenyl>carbamate(137302-30-8)

Safety Data

• Hazardous Substances Data: 137302-30-8(Hazardous Substances Data)

Upstream product

• 137429-58-4 1,1-dimethylethyl <1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>carbamate 
• 118233-28-6 (3R,4S)-4-tert-Butoxycarbonylamino-5-cyclohexyl-2,2-difluoro-3-hydroxy-pentanoic acid 
• 103322-58-3 ethyl 4(S)-<(tert-butyloxycarbonyl)amino>-5-(cyclohexylmethyl)-2,2-difluoro-3(R)-hydroxypentanoate 
• 98105-42-1 (S)-2-(t-butoxycarbonylamino)-3-cyclohexyl-1-propanal 
• 2038-03-1 4-(2-AMINOETHYL)MORPHOLINE 
• 90600-20-7 (2S)-2-[(tert-butoxycarbonyl)amino]pent-4-enoic acid 
• 134334-91-1 (1S,2R)-<1-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholino)ethyl>amino>-2-hydroxy-4-oxobutyl>amine 

Downstream Products

• 137302-69-3 N-<(1,1-dimethylethoxy)carbonyl>-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-77-3 N-<(1,1-dimethylethoxy)carbonyl>-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-67-1 N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-31-9 N-(4-morpholinylsulfonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-68-2 N-<(4-methyl-1-piperazinyl)sulfonyl>-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-62-6 β-hydroxy-N-(4-morpholinylsulfonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-70-6 N-<1-oxo-3-(3-pyridinyl)propyl>-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-78-4 N-<3-(3-pyridinyl)-1-oxopropyl>-L-phenylalanyl-N-<1-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-73-9 N-(4-morpholinylcarbonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-82-0 N-(1-piperazinylsulfonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-35-3 N-(4-morpholinylsulfonyl)-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-75-1 N-<(4-methyl-1-piperazinyl)sulfonyl>-L-phenylalanyl-N-<1-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-60-4 O-methyl-N-(4-morpholinylsulfonyl)-L-tyrosyl-N-<1-(S)-(cyclohexylmethyl)-3,3-difluoro-2(R)-hydroxy-4-<<2-(4-morpholinyl)ethyl>amino>-4-oxobutyl>-4,5-didehydro-L-norvalinamide 
• 137302-65-9 N-(4-morpholinylsulfonyl)-β-oxo-L-phenylalanyl-N-<1(S)-(cyclohexylmethyl)-3,3-difluoro-4-<<2-(4-morpholinyl)ethyl>amino>-2,4-dioxobutyl>-4,5-didehydro-L-norvalinamide 

Relevant articles and documents

Design and Synthesis of Potent, Selective, and Orally Active Fluorine-Containing Renin Inhibitors

A series of primate renin inhibitors containing difluorocarbinol and difluoroketone groups at the P1 - P1' position have been synthesized and studied both in vitro and in vivo.In vitro, the compounds were evaluated as inhibitors of m